Jennifer Humes

CIK: 0002058012

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (16.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)3 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ROIV

Roivant Sciences Ltd.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

ROIV
Roivant Sciences Ltd.
Sep 20, 2026
Tax Payment(F)
Direct
3.9K shares at avg. $39.77$154K
ROIV
Roivant Sciences Ltd.
Jun 20, 2026
Tax Payment(F)
Direct
3.6K shares at avg. $31.43$113K
ROIV
Roivant Sciences Ltd.
Apr 20, 2026
Award(A)
Direct
29.2K shares-
ROIV
Roivant Sciences Ltd.
Apr 8, 2026
Sale(S)
Direct
13.5K shares at avg. $28.37$384K
ROIV
Roivant Sciences Ltd.
Mar 20, 2026
Tax Payment(F)
Direct
14.5K shares at avg. $27.70$402K
ROIV
Roivant Sciences Ltd.
Mar 20, 2025
Award(A)
Direct
112.3K shares-

		Type	Shares	Price		Ownership
Sep 20, 2026	ROIV Roivant Sciences Ltd.	Tax Payment(F)	3,880	$39.77	$154,308	Direct
Jun 20, 2026	ROIV Roivant Sciences Ltd.	Tax Payment(F)	3,582	$31.43	$112,582	Direct
Apr 20, 2026	ROIV Roivant Sciences Ltd.	Award(A)	29,173	-	$0	Direct
Apr 8, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	13,538	$28.37	$384,073	Direct
Mar 20, 2026	ROIV Roivant Sciences Ltd.	Tax Payment(F)	14,526	$27.70	$402,370	Direct
Mar 20, 2025	ROIV Roivant Sciences Ltd.	Award(A)	112,255	-	-	Direct

1-6 of 6 transactions

About Humes Jennifer

Humes Jennifer (SEC CIK 0002058012) files insider reports with the SEC as Chief Accounting Officer of Roivant Sciences Ltd. (ROIV).

Signal8 holds 7 ownership filings by Humes Jennifer (1 Form 3, 6 Form 4), filed between Feb 25, 2025 and Sep 22, 2026. Those filings report 6 transactions, from Mar 20, 2025 to Sep 20, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Humes Jennifer's filings is in LONDON.

Recent filings by Humes Jennifer

Sep 20, 2026: Tax withholding of ROIV shares (Form 4, code F).
Jun 20, 2026: Tax withholding of ROIV shares (Form 4, code F).
Apr 20, 2026: Grant or award of ROIV shares (Form 4, code A).
Apr 8, 2026: Open-market sale of ROIV shares (Form 4, code S).
Mar 20, 2026: Tax withholding of ROIV shares (Form 4, code F).

Other insiders filing for Roivant Sciences Ltd. (ROIV)

Venker Eric, President & Immunovant CEO
Oren Ilan, Director
Epperly Melissa B,, Director
MOMTAZEE JAMES C, Director
Sukhatme Mayukh, President & CIO
Gline Matthew, CEO

How to read Form 4 transaction codes